NKTR 192

Drug Profile

NKTR 192

Alternative Names: NKTR-192

Latest Information Update: 29 Sep 2014

Price : $50

At a glance

  • Originator Nektar Therapeutics
  • Class Drug conjugates; Opioid analgesics
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Acute pain; Migraine

Most Recent Events

  • 31 Jan 2014 Preclinical trials in Migraine in USA (Parenteral)
  • 31 Jan 2014 Preclinical trials in Acute pain in USA (Parenteral)
  • 31 Jan 2014 Discontinued - Phase-I for Acute pain (In volunteers) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top